Mar 29, 2019   SOURCE: PR NewsWire

Global Antidiuretic Drugs Market 2019-2023 with Avadel, CSL Limited, Ferring B.V., Novartis & Sanofi Dominating

DUBLIN, March 29, 2019 /PRNewswire/ -- The "Global Antidiuretic Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The antidiuretic drugs market will register a CAGR of almost 10% by 2023.

With the rapid onset of modernization, the lifestyle of people is also changing. The prevalence of such health conditions is rising globally due to the sedentary lifestyle. Furthermore, the high prevalence of conditions such as urinary incontinence and interstitial cystitis has been substantially contributing to the global antidiuretic drugs market.

According to the CDC, the prevalence of nocturia in the US during 2013-2014 was found to be nearly 25% of the population. and the prevalence rate increased to about 40% in the people affected with chronic kidney diseases. Such a high prevalence of chronic conditions leads to polyuria and nocturia, which, in turn, will help in driving the global antidiuretic drugs market.

Market Overview

Rising geriatric population

The prevalence of chronic conditions that lead to various urologic diseases, including polyuria and nocturia, increases with age, and these conditions are prevalent in the geriatric population. Furthermore, rapid developments in the healthcare facilities and advanced treatment options have increased the life expectancy of the geriatric population globally. Rising awareness about various health conditions has been substantially contributing to the higher life expectancy.

Stringent regulator policies

One of the major challenges faced by the pharmaceutical vendors is the stringent policies set by various regulatory bodies and governing authorities globally. The US FDA has increased the regulatory surveillance for the drugs treating rare diseases, to avoid any associated risks. Hence, the disappointing results in drugs performance lead to the postponement of marketing approvals, which, further hampers the market growth.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

    --  Market ecosystem
    --  Market characteristics
    --  Market segmentation analysis

PART 04: MARKET SIZING

    --  Market definition
    --  Market sizing 2018
    --  Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

    --  Bargaining power of buyers
    --  Bargaining power of suppliers
    --  Threat of new entrants
    --  Threat of substitutes
    --  Threat of rivalry
    --  Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

    --  Market segmentation by application
    --  Comparison by application
    --  Autoimmune diseases - Market size and forecast 2018-2023
    --  Urologic diseases - Market size and forecast 2018-2023
    --  Other applications - Market size and forecast 2018-2023
    --  Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

    --  Geographic segmentation
    --  Geographic comparison
    --  North America - Market size and forecast 2018-2023
    --  Europe - Market size and forecast 2018-2023
    --  Asia - Market size and forecast 2018-2023
    --  ROW - Market size and forecast 2018-2023
    --  Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

    --  Market drivers
    --  Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

    --  Overview
    --  Landscape disruption
    --  Competitive scenario

PART 13: VENDOR ANALYSIS

    --  Vendors covered
    --  Vendor classification
    --  Market positioning of vendors
    --  Avadel
    --  CSL Limited
    --  Ferring B.V.
    --  Novartis AG
    --  Sanofi

PART 14: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/khskzk/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-antidiuretic-drugs-market-2019-2023-with-avadel-csl-limited-ferring-bv-novartis--sanofi-dominating-300820322.html

SOURCE Research and Markets